Preliminary scientific tests suggest conolidine could inhibit particular ion channels, decreasing neuronal excitability and limiting agony signals. This mechanism is especially relevant in neuropathic soreness, wherever irregular signaling brings about persistent pain. Furthermore, conolidine seems to impact G protein-coupled receptor (GPCR) pathwa